AJP - Endo AJP: Lung Cellular and Molecular Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab (September 3, 2002). doi:10.1152/ajpendo.00102.2002
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
284/1/E70    most recent
00102.2002v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McHugh, N. A
Right arrow Articles by Hey, J. A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McHugh, N. A
Right arrow Articles by Hey, J. A

Articles in PresS, published online ahead of print September 3, 2002
Am J Physiol Endocrinol Metab, 10.1152/ajpendo.00102.2002
Submitted on March 7, 2002
Accepted on August 28, 2002

In vivo rat assay: bone remodeling and steroid effects on juvenile bone by pQCT quantification in 7 days

Nansie A McHugh1*, Haydee M Vercesi1, Robert W Egan1, and John A Hey1

1 Department of Allergy, Schering-Plough Research Institute, Kenilworth, NJ, USA

* To whom correspondence should be addressed. E-mail: nansie.mchugh{at}spcorp.com.

Anesthetized Sprague-Dawley weanling rats were scanned for bone mineral density (BMD) values after 7 days treatment to determine if resorption/growth at the proximal tibia can be quantified by pQCT scanning techniques. Because the weanling rat is in a rapid growth stage, all groups showed significant increases in change from baseline values of BMD. Bisphosphonate treatment produced significant dose-related changes in BMD with average increases of 195% and 241% (10µg/kg and 20µg/kg) versus 86% in control rats. We further characterized this model to determine effects of steroids on growing bone. Graded doses of glucocorticoid (3.5, 7.0, 10.5, 14.0, 28.0 and 42.0mg/kg/week) caused no significant differences in trabecular BMD in 7 days between control and treated. Significant decreases in growth (weights) and increases in cortical bone area were observed indicating this model may be useful in comparing effects of non-steroid, anti-inflammatory alternatives on juvenile bone. Although the relevance of this model to adult disease remains to be elucidated, it also provides a tool for mechanistic evaluation of therapeutic modalities, or efficacy assessment for dose selection for longer term models.




This article has been cited by other articles:


Home page
J. Appl. Physiol.Home page
N. A. McHugh, H. M. Vercesi, R. W. Egan, and J. A. Hey
Receptor activator of NF-{kappa}B ligand arrests bone growth and promotes cortical bone resorption in growing rats
J Appl Physiol, August 1, 2003; 95(2): 672 - 676.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2002 by the American Physiological Society.